Please provide your email address to receive an email when new articles are posted on . Precise, timely testing for HIV can safely spare most HIV-exposed infants from needing pneumocystis jirovecii ...

Background. Current guidelines suggest that primary prophylaxis for Pneumocystis jiroveci pneumonia (PcP) can be safely stopped in human immunodeficiency virus (HIV)—infected patients who are ...

Regarding PCP prophylaxis in kidney recipients not tolerating trimethoprim-sulfamethoxazole (TMP-SMX): most solid organ recipients receive TMP-SMX prophylaxis for prevention of PCP. TMP-SMX is ...

The answer to this question is not easy because various centers are handling this situation differently, and there are no comparison trials in the literature that can help to clarify the answer. One ...

Please provide your email address to receive an email when new articles are posted on . One patient in a large cohort of individuals with autoimmune blistering diseases developed pneumocystis ...

Based on the study findings, researchers concluded that exposures of rezafungin needed for PCP prophylaxis will be achieved in most patients (≥ 90%) with doses as low as 50 mg per week.

Chemoprophylaxis for Pneumocystis carinii pneumonia (PCP) is routinely given after allogeneic blood or marrow transplantation. We evaluated the effectiveness of dapsone prophylaxis (50 mg orally twice ...

Pneumocystis pneumonia is a serious disease caused by a fungal pathogen called Pneumocystis jiroveci. Although it is typically seen as an opportunistic infection linked to HIV and AIDS, it is also ...

BOSTON—National guidelines from the American Society of Transplantation recommend antibiotic prophylaxis against Pneumocystis jiroveci pneumonia for at least six months after renal transplantation.